These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30940760)

  • 1. AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.
    Ponatshego PL; Lawrence DS; Youssouf N; Molloy SF; Alufandika M; Bango F; Boulware DR; Chawinga C; Dziwani E; Gondwe E; Hlupeni A; Hosseinipour MC; Kanyama C; Meya DB; Mosepele M; Muthoga C; Muzoora CK; Mwandumba H; Ndhlovu CE; Rajasingham R; Sayed S; Shamu S; Tsholo K; Tugume L; Williams D; Maheswaran H; Shiri T; Boyer-Chammard T; Loyse A; Chen T; Wang D; Lortholary O; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN; Niessen LW
    BMJ Open; 2019 Apr; 9(4):e026288. PubMed ID: 30940760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
    Lawrence DS; Youssouf N; Molloy SF; Alanio A; Alufandika M; Boulware DR; Boyer-Chammard T; Chen T; Dromer F; Hlupeni A; Hope W; Hosseinipour MC; Kanyama C; Lortholary O; Loyse A; Meya DB; Mosepele M; Muzoora C; Mwandumba HC; Ndhlovu CE; Niessen L; Schutz C; Stott KE; Wang D; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN
    Trials; 2018 Nov; 19(1):649. PubMed ID: 30470259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial.
    Lawrence DS; Muthoga C; Meya DB; Tugume L; Williams D; Rajasingham R; Boulware DR; Mwandumba HC; Moyo M; Dziwani EN; Maheswaran H; Kanyama C; Hosseinipour MC; Chawinga C; Meintjes G; Schutz C; Comins K; Bango F; Muzoora C; Jjunju S; Nuwagira E; Mosepele M; Leeme T; Ndhlovu CE; Hlupeni A; Shamu S; Boyer-Chammard T; Molloy SF; Youssouf N; Chen T; Shiri T; Jaffar S; Harrison TS; Jarvis JN; Niessen LW;
    Lancet Glob Health; 2022 Dec; 10(12):e1845-e1854. PubMed ID: 36400090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial.
    Molefi M; Chofle AA; Molloy SF; Kalluvya S; Changalucha JM; Cainelli F; Leeme T; Lekwape N; Goldberg DW; Haverkamp M; Bisson GP; Perfect JR; Letang E; Fenner L; Meintjes G; Burton R; Makadzange T; Ndhlovu CE; Hope W; Harrison TS; Jarvis JN
    Trials; 2015 Jun; 16():276. PubMed ID: 26081985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Lived Experience Of Participants in an African RandomiseD trial (LEOPARD): protocol for an in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitis.
    Lawrence DS; Tsholo K; Ssali A; Mupambireyi Z; Hoddinott G; Nyirenda D; Meya DB; Ndhlovu C; Harrison TS; Jarvis JN; Seeley J
    BMJ Open; 2021 Apr; 11(4):e039191. PubMed ID: 33820784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
    Jarvis JN; Lawrence DS; Meya DB; Kagimu E; Kasibante J; Mpoza E; Rutakingirwa MK; Ssebambulidde K; Tugume L; Rhein J; Boulware DR; Mwandumba HC; Moyo M; Mzinganjira H; Kanyama C; Hosseinipour MC; Chawinga C; Meintjes G; Schutz C; Comins K; Singh A; Muzoora C; Jjunju S; Nuwagira E; Mosepele M; Leeme T; Siamisang K; Ndhlovu CE; Hlupeni A; Mutata C; van Widenfelt E; Chen T; Wang D; Hope W; Boyer-Chammard T; Loyse A; Molloy SF; Youssouf N; Lortholary O; Lalloo DG; Jaffar S; Harrison TS;
    N Engl J Med; 2022 Mar; 386(12):1109-1120. PubMed ID: 35320642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.
    Rajasingham R; Rolfes MA; Birkenkamp KE; Meya DB; Boulware DR
    PLoS Med; 2012; 9(9):e1001316. PubMed ID: 23055838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries.
    Rajasingham R; Nalintya E; Israelski DM; Meya DB; Larson BA; Boulware DR
    Med Mycol; 2022 Feb; 60(2):. PubMed ID: 35026017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.
    Leenders AC; Reiss P; Portegies P; Clezy K; Hop WC; Hoy J; Borleffs JC; Allworth T; Kauffmann RH; Jones P; Kroon FP; Verbrugh HA; de Marie S
    AIDS; 1997 Oct; 11(12):1463-71. PubMed ID: 9342068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial.
    Jadhav MP; Bamba A; Shinde VM; Gogtay N; Kshirsagar NA; Bichile LS; Mathai D; Sharma A; Varma S; Digumarathi R
    J Postgrad Med; 2010; 56(2):71-5. PubMed ID: 20622383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?
    Harrison TS; Lawrence DS; Mwandumba HC; Boulware DR; Hosseinipour MC; Lortholary O; Meintjes G; Mosepele M; Jarvis JN
    Clin Infect Dis; 2023 Mar; 76(5):944-949. PubMed ID: 36166405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda.
    Lawrence DS; Ssali A; Moshashane N; Nabaggala G; Maphane L; Harrison TS; Meya DB; Jarvis JN; Seeley J
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010825. PubMed ID: 36279300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.
    Jarvis JN; Leeme TB; Molefi M; Chofle AA; Bidwell G; Tsholo K; Tlhako N; Mawoko N; Patel RKK; Tenforde MW; Muthoga C; Bisson GP; Kidola J; Changalucha J; Lawrence D; Jaffar S; Hope W; Molloy SLF; Harrison TS
    Clin Infect Dis; 2019 Jan; 68(3):393-401. PubMed ID: 29945252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa.
    Miot J; Leong T; Takuva S; Parrish A; Dawood H
    BMC Health Serv Res; 2021 Apr; 21(1):305. PubMed ID: 33823842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa.
    Chen T; Mwenge L; Lakhi S; Chanda D; Mwaba P; Molloy SF; Gheorghe A; Griffiths UK; Heyderman RS; Kanyama C; Kouanfack C; Mfinanga S; Chan AK; Temfack E; Kivuyo S; Hosseinipour MC; Lortholary O; Loyse A; Jaffar S; Harrison TS; Niessen LW;
    Clin Infect Dis; 2019 Aug; 69(4):588-595. PubMed ID: 30863852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis.
    Tenforde MW; Gertz AM; Lawrence DS; Wills NK; Guthrie BL; Farquhar C; Jarvis JN
    J Int AIDS Soc; 2020 Jan; 23(1):e25416. PubMed ID: 31957332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study.
    Ahimbisibwe C; Kwizera R; Ndyetukira JF; Kugonza F; Sadiq A; Hullsiek KH; Williams DA; Rhein J; Boulware DR; Meya DB
    BMC Infect Dis; 2019 Jun; 19(1):558. PubMed ID: 31242860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.
    Merry M; Boulware DR
    Clin Infect Dis; 2016 Jun; 62(12):1564-8. PubMed ID: 27009249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries.
    Loyse A; Thangaraj H; Easterbrook P; Ford N; Roy M; Chiller T; Govender N; Harrison TS; Bicanic T
    Lancet Infect Dis; 2013 Jul; 13(7):629-37. PubMed ID: 23735626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.